Reach Us +12 184512974


RNA Transcription and splicing errors as a source of cancer Frameshift Neoantigens for Vaccines

The success of checkpoint inhibitors in cancer therapy is largely attributed to activating the patient’s immune response to their tumor’s neoantigens arising from DNA mutations. This realization has motivated the interest in personal cancer vaccines based on sequencing the patient’s tumor DNA to discover neoantigens. Here we propose an additional, unrecognized source of tumor neoantigens. We show that errors in transcription of microsatellites(MS) and mis-splicing of exons create highly immunogenic frameshift(FS) neoantigens in tumors


Fatemeh Babaie

Abstract | PDF

Share this  Facebook  Twitter  LinkedIn  Google+

buca escort karşıyaka escort

rolex replica